Summit Therapeutics Inc. Cash Flows From Used In Operations
Summit Therapeutics Inc. (SMMT) reported Cash Flows From Used In Operations of -GBP 6.70 million for the 3-month period ending 2020-03-31, per its 6-K filed 2020-06-02.
Discontinued › Notes
ifrs-full:CashFlowsFromUsedInOperations · last filed 2020-06-02
- Summit Therapeutics Inc. cash flows from used in operations for the quarter ending 2020-03-31 was -6.70M GBP.
- Summit Therapeutics Inc. cash flows from used in operations for the quarter ending 2019-10-31 was -6.88M GBP.
- Summit Therapeutics Inc. cash flows from used in operations for the quarter ending 2019-07-31 was -7.78M GBP.
- Summit Therapeutics Inc. cash flows from used in operations for the quarter ending 2019-04-30 was -3.50M GBP.
| Period end | Cash Flows From Used In Operations 3 month | Cash Flows From Used In Operations 3 month as first filed | Cash Flows From Used In Operations 6 month | Cash Flows From Used In Operations 6 month as first filed | Cash Flows From Used In Operations 9 month | Cash Flows From Used In Operations 9 month as first filed | Cash Flows From Used In Operations 11 month | Cash Flows From Used In Operations 12 month | Cash Flows From Used In Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | -6.70M GBP 6-K · filed 2020-06-02 | ||||||||
| 2019-12-31 | -21.87M GBP 20-F · filed 2020-04-30 | ||||||||
| 2019-10-31 | -6.88M GBP derived: 6-K 9 month − 6-K 6 month · filed 2019-12-17 | -14.65M GBP derived: sum of 2 quarters · filed 2019-12-17 | -18.16M GBP 6-K · filed 2019-12-17 | ||||||
| 2019-07-31 | -7.78M GBP derived: 6-K 6 month − 6-K 3 month · filed 2019-10-11 | -11.28M GBP 6-K · filed 2019-10-11 | |||||||
| 2019-04-30 | -3.50M GBP 6-K · filed 2019-06-12 | ||||||||
| 2019-03-31 | -8.10M GBP 6-K · filed 2020-06-02 | ||||||||
| 2019-01-31 | -3.99M GBP derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | -8.51M GBP derived: sum of 2 quarters · filed 2020-04-30 | -19.34M GBP derived: sum of 3 quarters · filed 2020-04-30 | -26.30M GBP 20-F · filed 2020-04-30 | -26.95M GBP 20-F · filed 2019-03-29 | ||||
| 2018-10-31 | -4.52M GBP derived: 6-K 9 month − 6-K 6 month · filed 2019-12-17 | -15.35M GBP derived: sum of 2 quarters · filed 2019-12-17 | -22.31M GBP 6-K · filed 2019-12-17 | -22.55M GBP 6-K · filed 2018-12-11 | -31.48M GBP derived: sum of 4 quarters · filed 2020-04-30 | ||||
| 2018-07-31 | -10.83M GBP derived: 6-K 6 month − 6-K 3 month · filed 2019-10-11 | -17.79M GBP 6-K · filed 2019-10-11 | -17.95M GBP 6-K · filed 2018-09-20 | -26.96M GBP derived: sum of 3 quarters · filed 2020-04-30 | -37.33M GBP derived: sum of 4 quarters · filed 2020-04-30 | ||||
| 2018-04-30 | -6.96M GBP 6-K · filed 2019-06-12 | -7.04M GBP 6-K · filed 2018-06-05 | -16.13M GBP derived: sum of 2 quarters · filed 2020-04-30 | -26.50M GBP derived: sum of 3 quarters · filed 2020-04-30 | -16.91M GBP derived: sum of 4 quarters · filed 2020-04-30 | ||||
| 2018-01-31 | -9.17M GBP derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | -19.54M GBP derived: sum of 2 quarters · filed 2020-04-30 | -9.95M GBP derived: sum of 3 quarters · filed 2020-04-30 | -17.89M GBP 20-F · filed 2020-04-30 | -18.06M GBP 20-F · filed 2018-04-13 | ||||
| 2017-10-31 | -10.37M GBP derived: 6-K 9 month − 6-K 6 month · filed 2018-12-11 | -780.00K GBP derived: sum of 2 quarters · filed 2018-12-11 | -8.72M GBP 6-K · filed 2018-12-11 | ||||||
| 2017-07-31 | 9.59M GBP derived: 6-K 6 month − 6-K 3 month · filed 2018-09-20 | 1.65M GBP 6-K · filed 2018-09-20 | |||||||
| 2017-04-30 | -7.94M GBP 6-K · filed 2018-06-05 | ||||||||
| 2017-01-31 | 9.14M GBP 20-F · filed 2019-03-29 | ||||||||
| 2016-01-31 | -18.58M GBP 20-F · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |